subject area of
- A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events Journal Articles
- Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review Journal Articles
- Efficacy of Bisphosphonates in the Management of Skeletal Complications of Bone Metastases and Selection of Clinical Endpoints Journal Articles
- Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints. Journal Articles
- Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats. Journal Articles
- Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity Journal Articles
- Oral bisphosphonates Journal Articles
- Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate Journal Articles
- Patient Management, and Time and Health Care Resource Utilization Associated with the Use of Intravenous Bisphosphonates For Patients with Metastatic Bone Disease: A Delphi Study Journal Articles
- Pharmacological Treatment of Ankylosing Spondylitis Journal Articles
- Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update Journal Articles
- The Use of Zoledronic Acid, a Novel, Highly Potent Bisphosphonate, for the Treatment of Hypercalcemia of Malignancy Journal Articles
- Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study Journal Articles
- Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials Journal Articles
- Zoledronic Acid and Survival in Breast Cancer Patients with Bone Metastases and Elevated Markers of Osteoclast Activity Journal Articles
- Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity. Journal Articles
- Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion Journal Articles